Lifeline Biotech ( LLBT LLBO)

[kodiak149]

LBTN MastaScope(TM) Draws Substantial Attention at Fall Chinese National Medical Equipment Show

RENO, Nev.--(Business Wire)--Nov. 4, 2005--
Lifeline Biotechnologies, Inc. (Pink Sheets: LBTN)
announced today that MastaScope(TM) has been drawing substantial
attention at the Fall Chinese National Medical Equipment Show
currently in process. The show attendees' are among the world's first
to see the company's new MastaScope(TM) being demonstrated first-hand.
This excitement surrounding the MastaScope(TM) reveals how the
device can assist in the early detection of breast cancer, is being
well received among the Chinese medical community. The device was
publicly unveiled in China for the first time at the event. Shanghai
Science Medical Equipment Co, Ltd., who is Lifeline Biotechnologies
Chinese distributor, has sales representation in 17 of China's 26
providences, which make up a majority of the Chinese population.
"Based on the reception the MastaScope(TM) has received at the
Chinese Medical Equipment Show, we anticipate it will have a favorable
impact on sales for 2005. We will then be able to formulate a sales
plan and expectation for 2006," stated Jim Holmes, CEO of Lifeline
Biotechnologies, Inc.

About Lifeline Biotechnologies, Inc.

Lifeline Biotechnologies, Inc. is a company with innovative
medical technologies committed to the improvement of the quality of
life through exceptional health care systems. These technologies focus
on prevention, early detection, diagnosis and quick recovery of a
number of disease conditions. The company's Cancer Detection
technologies deal with cutting edge innovation to assist practicing
physicians in the delivery of quality medical care. The MastaScope(TM)
is used in the early detection of cancer and other abnormalities of
the breast. The MastaScope(TM) has completed development and has
entered the marketplace in the US and internationally. The First
Warning System(TM) for assisting in the early detection of breast
cancer and the OvaScope(TM) for assisting in the early detection of
ovarian cancer are continuing to be developed by the company. More
information is available at the company's website: www.lbti.com.

Safe Harbor

This release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 27E
of the Securities Act of 1934. Statements contained in this release
that are not historical facts may be deemed to be forward-looking
statements. Investors are cautioned that forward-looking statements
are inherently uncertain. Actual performance and results may differ
materially from that projected or suggested herein due to certain
risks and uncertainties including, without limitation, ability to
obtain financing and regulatory and shareholder approval for
anticipated actions.

Big Apple Consulting USA, Inc.
for Lifeline Biotechnologies, Inc.
Matt Maguire, 407-884-0444 or 1-866-THE-APPLE

Copyright Business Wire 2005
04Nov05 13:00 GMT
Symbols:
us;LBTN
Source BW Business Wire
Categories:
MST/I/BTC MST/I/MDV MST/L/EN MST/R/ASI MST/R/CN MST/R/NME MST/R/US
MST/R/US/NV TGT/BWB